The U.S. Supreme Court announced Friday that it will hear a case that will settle a decades-long battle over whether pharmaceutical giants can pay competitors to prevent selling a generic form of a best-selling drug, a practice known as reverse payment patent settlements. Over the years, federal regulators have said the practice is in violation of antitrust law; pharmaceutical companies, on the other hand, argue the practice settles patent disputes and is a way to protect their product into which they have poured billions of dollars. A federal appeals court in Philadelphia was the first time the practice has been ruled in violation of competition law; three previous federal circuit courts of appeal have ruled that the practice is not illegal. The Federal Trade Commission was the first to file the suit in 2009, arguing that blocking generic drug sales raises prices and hurts consumers. A bill was drafted last year in Congress to outlaw the practice of paying off makers of generic forms of drugs, but it never made it to the floor.
Featured News
Trump’s Defamation Case Against New York Times Advances in Federal Court
Nov 19, 2026 by
CPI
Musk’s xAI Faces Skeptical US Judges Over California AI Disclosure Law
Nov 19, 2026 by
CPI
Italy Ends Vorwerk Antitrust Probe After Consumer Compensation Deal
Nov 19, 2026 by
CPI
Canada Wins Court Order to Advance Gap, Old Navy Advertising Probe
Nov 19, 2026 by
CPI
Russia Orders Major Retailers to Disclose Food Pricing Data in Antitrust Review
Nov 19, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Labor Market Collusion
Nov 19, 2026 by
CPI
From Price-Fixing to Wage-Fixing: Are Labor Markets the Next Frontier of Public and Private Competition Law Enforcement?
Nov 19, 2026 by
Giulia Rurali & Carsten Krüger
Damage Estimation and Labor Market Collusion
Nov 19, 2026 by
Louis D. Pape
Recent Developments of Labor Market Collusion in the EU: The Dialogue Between Delivery Hero and Tondela
Nov 19, 2026 by
Catarina Vieira Peres & Rita Ferreira Gomes
Enforcement in Labor Collusion and Monopsony: Trends and Challenges
Nov 19, 2026 by
Leyla Karakas & Anna Meyendorff